Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytochrome P450 humanised mice.

Frank J Gonzalez1

  • 1Laboratory of Metabolism, National Cancer Institute, Building 37, Room 3106B, Bethesda, MD 20892, USA. fjgonz@helix.nih.gov

Human Genomics
|December 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity.

Journal of hepatology·2015
Same author

Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.

Biochimica et biophysica acta·2015
Same author

Modulation of colon cancer by nutmeg.

Journal of proteome research·2015
Same author

Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.

American journal of physiology. Renal physiology·2015
Same author

Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism.

Laboratory investigation; a journal of technical methods and pathology·2015
Same author

Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury.

Free radical biology & medicine·2015
Same journal

Mutational spectrum of SLC26A4 and SLC26A5 associated with hereditary hearing loss in Moroccan families.

Human genomics·2026
Same journal

National genomic projects in Asia and Africa: a review.

Human genomics·2026
Same journal

Analysis of whole-exome sequencing data from nearly 10,000 Iranian individuals: identification of recessive mitochondrial disease variants and proposal of a population-specific carrier screening panel.

Human genomics·2026
Same journal

Replicating lipid micelles: a feasible precursor to the origin of life and the earliest appearance of genomes.

Human genomics·2026
Same journal

Beckwith-Wiedemann spectrum exhibiting a 46,XY karyotype caused by genome-wide paternal uniparental heterodisomy: a case report.

Human genomics·2026
Same journal

Dynamic responses in the human methylome to exertional heat exhaustion, heat injury, and heat stroke.

Human genomics·2026
See all related articles

Humanized mice offer a new way to study how the body processes foreign compounds, like drugs. These models help predict drug metabolism and assess risks from environmental toxins.

Area of Science:

  • Pharmacology and Toxicology
  • Biochemistry
  • Genetics

Background:

  • Humans encounter numerous foreign compounds (xenobiotics) from drugs, pollutants, and diet.
  • Xenobiotics are primarily metabolized in the liver by enzymes like cytochromes P450 (P450s) to facilitate elimination.
  • Some xenobiotics can be converted into toxic electrophiles, potentially leading to cell damage and cancer.

Purpose of the Study:

  • To explore the utility of novel humanized mouse models for studying xenobiotic metabolism.
  • To evaluate the potential of these models for predicting human drug metabolism and pharmacokinetics.
  • To assess the application of humanized mice in human risk assessment for environmental xenobiotics.

Main Methods:

  • Utilizing humanized mouse models engineered to express key human drug-metabolizing enzymes.

Related Experiment Videos

  • Investigating xenobiotic metabolism, pharmacokinetics, and pharmacodynamics in vivo using these models.
  • Comparing metabolic profiles and toxicological outcomes with existing methods using human liver extracts and recombinant P450s.

    • Main Results:

    • Humanized mice expressing CYP2D6 and CYP3A4 demonstrated the feasibility of this approach.
    • These models provide a valuable in vivo system for studying human drug metabolism.
    • The models show promise for predicting inter-individual variability in drug response and toxicity.

    Conclusions:

    • Humanized mouse models represent a significant advancement in xenobiotic metabolism research.
    • They offer a powerful tool for drug development, pharmacokinetic studies, and risk assessment.
    • Further development and application of these models will enhance our understanding of human exposure to foreign compounds.